Jill Feldman, Lung Cancer Patient and Advocate, Co-Founder of EGFR Resisters, shared a post on X by Oncogene Cancer Research, adding:
“One diagnosis – Lung cancer
Five different paths – No One Size Fits All
Each story is part of a tapestry of stories woven together that creates something none of us could build alone
Quoting Oncogene Cancer Research’s post:
“One diagnosis. Five different paths.
Jill Feldman, Yvonne Diaz, Leah Phillips, and Samantha M. remind us that lung cancer isn’t one story. It’s many.
It’s why we need more research. It’s why we need treatments to be ever more personalised.”
More posts featuring Jill Feldman.
